tradingkey.logo
tradingkey.logo
Search

Allarity Therapeutics Granted FDA Fast Track Designation For Stenoparib For The Treatment Of Advanced Ovarian Cancer

ReutersAug 26, 2025 12:22 PM
facebooktwitterlinkedin

- Allarity Therapeutics Inc ALLR.O:

  • ALLARITY THERAPEUTICS GRANTED FDA FAST TRACK DESIGNATION FOR STENOPARIB FOR THE TREATMENT OF ADVANCED OVARIAN CANCER

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI